JP2008524236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524236A5 JP2008524236A5 JP2007546887A JP2007546887A JP2008524236A5 JP 2008524236 A5 JP2008524236 A5 JP 2008524236A5 JP 2007546887 A JP2007546887 A JP 2007546887A JP 2007546887 A JP2007546887 A JP 2007546887A JP 2008524236 A5 JP2008524236 A5 JP 2008524236A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- alkyl
- halogen
- hydroxyphenyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1c(cc(cc2*)O)c2cc(-c(cc2F)ccc2O)c1 Chemical compound *c1c(cc(cc2*)O)c2cc(-c(cc2F)ccc2O)c1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63714404P | 2004-12-17 | 2004-12-17 | |
| PCT/US2005/045375 WO2006065968A2 (en) | 2004-12-17 | 2005-12-15 | The uses of estrogen beta agonists to treat cognitive diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008524236A JP2008524236A (ja) | 2008-07-10 |
| JP2008524236A5 true JP2008524236A5 (cg-RX-API-DMAC7.html) | 2009-02-05 |
Family
ID=36143266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546887A Pending JP2008524236A (ja) | 2004-12-17 | 2005-12-15 | エストロゲンβアゴニストについての新規用途 |
Country Status (20)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1984028A2 (en) * | 2006-02-14 | 2008-10-29 | Wyeth a Corporation of the State of Delaware | Aqueous pharmaceutical formulations of er selective ligands |
| WO2010105035A2 (en) * | 2009-03-11 | 2010-09-16 | University Of South Florida | Prevention, treatment, and diagnosis of alzheimer's disease through electromagnetic field exposure |
| US10149982B2 (en) | 2009-03-11 | 2018-12-11 | University Of South Florida | Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatment |
| US10758496B2 (en) * | 2014-09-02 | 2020-09-01 | The Regents Of The University Of California | Estrogen receptor ligand treatment for neurodegenerative diseases |
| WO2018183800A1 (en) * | 2017-03-30 | 2018-10-04 | Marquette University | Substituted (4'-hydroxyphenyl)cycloalkane and (4'-hydroxyphenyl)cycloalkene compounds and uses thereof as selective agonists of the estrogen receptor beta isoform for enhanced memory consolidation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990078A (en) * | 1995-07-14 | 1999-11-23 | The Trustees Of Columbia University In The City Of New York | Means of increasing estrogen receptor levels in neural tissue |
| FR2739777B1 (fr) * | 1995-10-11 | 1997-11-14 | Cird Galderma | Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose |
| WO1998021946A1 (en) * | 1996-11-18 | 1998-05-28 | Internutria, Inc. | Composition and treatment for persistent reproductive transition symptoms |
| US20040092010A1 (en) * | 2002-04-15 | 2004-05-13 | Ariel Ruiz I Altaba | Method of proliferating and inducing brain stem cells to differentiate to neurons |
| TR200102992T2 (tr) * | 1999-04-16 | 2004-12-21 | Astrazeneca Ab | ß östrojen reseptörü ligandları. |
| JP2004515496A (ja) * | 2000-12-07 | 2004-05-27 | アストラゼネカ・アクチエボラーグ | ベンズイミダゾール治療剤 |
| WO2002051821A1 (en) * | 2000-12-22 | 2002-07-04 | Astrazeneca Ab | Therapeutic compounds |
| US20030096264A1 (en) * | 2001-06-18 | 2003-05-22 | Psychiatric Genomics, Inc. | Multi-parameter high throughput screening assays (MPHTS) |
| DE60116109T2 (de) * | 2001-11-07 | 2006-09-07 | Schering Ag | In vitro Screening nach Liganden des Östrogenrezeptors |
| UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
| TWI306450B (en) * | 2001-12-13 | 2009-02-21 | Wyeth Corp | Substituted phenyl naphthalenes as estrogenic agents |
| TW200301107A (en) * | 2001-12-13 | 2003-07-01 | Wyeth Corp | Substituted 6H-dibenzo[c,h]chromenes as estrogenic agents |
| US6774248B2 (en) * | 2001-12-18 | 2004-08-10 | Wyeth | Substituted 2-phenyl benzofurans as estrogenic agents |
| WO2004026290A1 (en) * | 2002-09-19 | 2004-04-01 | Merck & Co., Inc. | Method for treating depression and/or anxiety |
| CL2004000985A1 (es) * | 2003-05-16 | 2005-01-14 | Wyeth Corp | Compuestos derivados de fenilquinolinas; composicion farmaceutica, proceso de preparacion; y uso para tratar osteoporosis, enfermedad de paget, dano vascular, osteoartritis, cancer oseo, cancer ovarico, cancer prostatico, hipercolesterolemia, aterosc |
| US7157492B2 (en) * | 2004-02-26 | 2007-01-02 | Wyeth | Dibenzo chromene derivatives and their use as ERβ selective ligands |
| JP2008505095A (ja) * | 2004-07-01 | 2008-02-21 | ワイス | エストロゲンリガンドとしての四環式化合物 |
-
2005
- 2005-12-15 RU RU2007120254/14A patent/RU2007120254A/ru not_active Application Discontinuation
- 2005-12-15 EP EP05854149A patent/EP1824478A2/en not_active Withdrawn
- 2005-12-15 MX MX2007007347A patent/MX2007007347A/es unknown
- 2005-12-15 US US11/304,037 patent/US20060135574A1/en not_active Abandoned
- 2005-12-15 KR KR1020077013666A patent/KR20070086329A/ko not_active Withdrawn
- 2005-12-15 AR ARP050105297A patent/AR051844A1/es unknown
- 2005-12-15 TW TW094144391A patent/TW200637545A/zh unknown
- 2005-12-15 AU AU2005316561A patent/AU2005316561A1/en not_active Abandoned
- 2005-12-15 CN CNA2005800434508A patent/CN101321524A/zh active Pending
- 2005-12-15 BR BRPI0519111-4A patent/BRPI0519111A2/pt not_active IP Right Cessation
- 2005-12-15 PA PA20058656601A patent/PA8656601A1/es unknown
- 2005-12-15 CA CA002590258A patent/CA2590258A1/en not_active Abandoned
- 2005-12-15 JP JP2007546887A patent/JP2008524236A/ja active Pending
- 2005-12-15 GT GT200500370A patent/GT200500370A/es unknown
- 2005-12-15 WO PCT/US2005/045375 patent/WO2006065968A2/en not_active Ceased
-
2006
- 2006-01-03 PE PE2006000026A patent/PE20061113A1/es not_active Application Discontinuation
-
2007
- 2007-05-24 NO NO20072658A patent/NO20072658L/no not_active Application Discontinuation
- 2007-05-31 IL IL183604A patent/IL183604A0/en unknown
- 2007-06-14 NI NI200700152A patent/NI200700152A/es unknown
- 2007-06-15 ZA ZA200705103A patent/ZA200705103B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Uthayathas | Versatile effects of sildenafil: recent pharmacological applications | |
| Forrer et al. | Experimental physiological studies with lysergic acid diethylamide (LSD-25) | |
| Yanagisawa | Functions and dysfunctions of the basal ganglia in humans | |
| Koshino et al. | Enhancement of rolandic mu-rhythm by pattern vision | |
| JP7506046B2 (ja) | 改善される運動性及び認知機能のためのアセチル-ロイシン又はその薬学的に許容される塩 | |
| CA2433858A1 (en) | Purine derivatives as purinergic receptor antagonists | |
| US20060252761A1 (en) | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine | |
| JP2003517437A (ja) | インビボでシチジンレベルを上昇させ、シチジン依存性のヒト疾患を治療するための方法 | |
| Sechi et al. | Restless legs syndrome and periodic limb movements after ischemic stroke in the right lenticulostriate region | |
| JP2022549335A5 (cg-RX-API-DMAC7.html) | ||
| RS67956B1 (sr) | Troriluzol za upotrebu u lečenju spinocerebelarne ataksije 3 (sca3) | |
| DE69936994T2 (de) | Verfahren zur behandlung von okularen neovaskularen erkrankungen | |
| CA2509251A1 (en) | Method of treating cognitive decline due to sleep deprivation and stress | |
| Ezenwanne | Current concepts in the neurophysiologic basis of sleep; a review | |
| Calne et al. | Dopamine agonists in Parkinson’s disease | |
| WO2012125400A1 (en) | Compositions and methods using adenosine a3 receptor antagonists for the treatment of inflammatory eye diseases | |
| DE69923338T2 (de) | Kombinationstherapie zur behandlung von hepatitis b infektionen | |
| RU2097034C1 (ru) | Фармацевтический препарат антиалкогольного и ноотропного действия | |
| RU2007120254A (ru) | Новые способы применения агонистов эстрогена бета | |
| Thompson | The dawn of the yawn: is yawning a warning? Linking neurological disorders | |
| CN109251155A (zh) | α-氨基酰胺衍生物及其用途 | |
| JP2005532339A (ja) | cGMP刺激性化合物 | |
| Rahm | Fundamental principles of pharmacology | |
| AU2010295445B2 (en) | Role of N-2 hydroxy-ethyl-piperazine-N'-2-ethane sulfonic acid (HEPES) in pain control and reversal of demyelinization injury | |
| US20070265238A1 (en) | Method for accelerating reentrainment of a circadian rhythm |